EMILY SAKS, MD
Obstetrics & Gynecology Physician in NEWARK, Delaware. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
EMILY SAKS, MD filed 910 Medicare Part D claims in 2023 as a Obstetrics & Gynecology Physician in NEWARK, Delaware, prescribing 48% generic.
- 910
- Part D claims, 2023
- 48%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
EMILY SAKS, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
910 Top 25% higher than 75% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
EMILY SAKS, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about EMILY SAKS, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Delaware
How Obstetrics & Gynecology Physician compares to other specialties among Delaware providers
Obstetrics & Gynecology Physician share within Delaware
Obstetrics & Gynecology Physician is one of the more visible NUCC categories in Delaware
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Obstetrics & Gynecology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Obstetrics & Gynecology Physician ABMS/AOA estimate
Est. board-certified rate (Obstetrics & Gynecology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Obstetrics & Gynecology Physician US NPIs
Specialty board-certified rate — Obstetrics & Gynecology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
EMILY SAKS, MD appears in the CMS NPPES registry as a Obstetrics & Gynecology Physician provider holding MD credentials at 4735 OGLETOWN STANTON RD, NEWARK, DE, 19713, with a listed phone of (302) 623-4055. NPI 1982760872 was issued on 12/28/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SAKS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 910 prescription claims written by this provider, covering 283 Medicare beneficiaries and totaling roughly $351K in drug spend, split 52% brand-name and 48% generic by claim count, with an opioid prescribing rate of 1.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Obstetrics & Gynecology Physician is a mid-sized specialty nationwide, with 44,313 enrolled providers across 56 states and an average of 179 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1982760872 |
|---|---|
| Specialty | Obstetrics & Gynecology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 12/28/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm EMILY SAKS, MD's current license status, disciplinary history, and board certifications with the Delaware Board of Medical Licensure in Delaware before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where EMILY SAKS, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for EMILY SAKS, MD. Source: openpaymentsdata.cms.gov.
Total received
$839
Largest payer
Medtronic, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
52% brand-name claims vs 48% generic, on 910 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,551
- Total Day Supply
- 43,154
- Brand vs Generic
- 52% brand / 48% generic
- Brand Drug Cost
- $318K
- Generic Drug Cost
- $33K
- Opioid Claims
- 12 (1.3% rate)
- Antibiotic Claims
- 131
Patient Demographics
- Average Patient Age
- 74.7 years
- Avg HCC Risk Score
- 1.14
- Gender Split
- 100% female / 0% male
- Age Distribution
- <65: 14, 65-74: 122, 75-84: 116, 85+: 31
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What EMILY SAKS, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Myrbetriq
Myrbetriq
369 claims
- Estradiol 78
Estradiol
78 claims
- Oxybutynin Chlorid… 72
Oxybutynin Chloride Er
72 claims
- Trospium Chloride Er 48
Trospium Chloride Er
48 claims
- Nitrofurantoin Mon… 45
Nitrofurantoin Mono-Macro
45 claims
- Gemtesa 41
Gemtesa
41 claims
- Sulfamethoxazole-T… 36
Sulfamethoxazole-Trimethoprim
36 claims
- Cephalexin 32
Cephalexin
32 claims
| Drug | Claims |
|---|---|
| Myrbetriq Mirabegron | 369 |
| Estradiol | 78 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 72 |
| Trospium Chloride Er Trospium Chloride | 48 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 45 |
| Gemtesa Vibegron | 41 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 36 |
| Cephalexin | 32 |
| Trospium Chloride | 28 |
| Methenamine Hippurate | 21 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Obstetrics & Gynecology Physician Overview
How EMILY SAKS, MD fits within the Obstetrics & Gynecology Physician landscape nationally.
EMILY SAKS, MD's 910 claims are above the specialty average of 179.
Nearby Obstetrics & Gynecology Physician Providers in Delaware
Other clinicians with the same primary specialty enrolled in Delaware, drawn from the same CMS NPPES roster as SAKS.
Compare Obstetrics & Gynecology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Delaware
Frequently Asked Questions
What is EMILY SAKS, MD's specialty? ▼
How much does EMILY SAKS, MD prescribe under Medicare Part D? ▼
Where is EMILY SAKS, MD located? ▼
What is EMILY SAKS, MD's NPI number? ▼
Does EMILY SAKS, MD prescribe more brand-name or generic drugs? ▼
Does EMILY SAKS, MD prescribe opioids? ▼
How many Obstetrics & Gynecology Physician providers are there in the US? ▼
What drugs does EMILY SAKS, MD prescribe most often? ▼
Does EMILY SAKS, MD accept Medicare? ▼
How can I verify EMILY SAKS, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology